Disease management programs in chronic heart failure: Position statement of the Heart Failure Working Group and the Working Group of the Cardiological Assistance and Care Personnel of the Austrian Society of Cardiology

TY - JOUR

T1 - Disease management programs in chronic heart failure

T2 - Position statement of the Heart Failure Working Group and the Working Group of the Cardiological Assistance and Care Personnel of the Austrian Society of Cardiology

AU - Moertl, Deddo

AU - Altenberger, Johann

AU - Bauer, Norbert

AU - Berent, Robert

AU - Berger, Rudolf

AU - Boehmer, Armin

AU - Ebner, Christian

AU - Fritsch, Margarethe

AU - Geyrhofer, Friedrich

AU - Huelsmann, Martin

AU - Poelzl, Gerhard

AU - Stefenelli, Thomas

N1 - Funding Information: Conflict of interest D. Moertl: speakers fee and/or consultant fees from Abbott, Merck, Novartis, ResMed, Roche Diagnostics, Servier, Vifor. J. Altenberger: Medical director of “Kardiomobil-Heimbetreuung für Herzinsuffizienzpatien-ten” Salzburg; speakers fee from Novartis, Servier, Orion-Pharma, St.-Jude, Menarini. N. Bauer: research grant, speakers fee and/or consultant fee from Bayer, Daiichi-Sankyo, Servier, AstraZeneca, Boehringer-Ingelheim, Lilly. R. Berent: medical director, Center for cardiovascular rehabilitation, HerzReha Bad Ischl, speakers fee and consultant of No-vartis, Boehringer Ingelheim, Merck, MSD, Servier, Pfizer, Amgen, Sanofi-Aventis. R. Berger: Research grant, speakers fee and consultant of Abbott, Amgen, Bayer, Biotronic, Boehringer Ingelheim, Cardinal Health, Medtronic, Novartis, Orion Pharma, Servier. A. Boehmer: director of RPP Kar-diologische Versorgung Modellregion Waldviertel, research grant, speakers fee or consultant of Novartis, Orion Pharma, Boehringer, Merck, Servier, Boston. C. Ebner: research grant, speakers fee by or consultant of Abbott, Merck, Novartis, Orion, Pfizer, Servier, Vifor. M. Fritsch: DGKS, nurse at the University Clinic of Salzburg, Cardiology Section, Heart Failure consultant, leading nurse of the “Cardiomobil” project of Salzburg. F. Geyrhofer: Kardiologischer Administrator Ordensklinikum Linz, speakers fee and consultant of Core. M. Huelsmann: research grant, speakers fee by or consultant of Abbott, Gebro, Merck, Novartis, Pfizer, Roche Diagnostics, MSD, Pint Pharma, Servier, Thermo Fisher. G. Poelzl: director of the HerzMobil Tyrol DMP. Research grant, speakers fee by or consultant of Abbott, Merck, Novartis, Orion, Pfizer, Servier, Vifor. T. Stefenelli: research grant from Sorin; board and speakers fees from Astra-Zeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Genericon, Menarini, MSD, No-vartis, Orion, Servier, Takeda, Vifor. None of the authors have a financial relationship with the Austrian Society of Cardiology, the institution which sponsored this manuscript. Funding Information: Open access funding provided by Medical University of Vienna. D. Moertl: speakers fee and/or consultant fees from Abbott, Merck, Novartis, ResMed, Roche Diagnostics, Servier, Vifor. J. Altenberger: Medical director of “Kardiomobil-Heimbetreuung für Herzinsuffizienzpatienten” Salzburg; speakers fee from Novartis, Servier, OrionPharma, St.-Jude, Menarini. N. Bauer: research grant, speakers fee and/or consultant fee from Bayer, Daiichi-Sankyo, Servier, AstraZeneca, Boehringer-Ingelheim, Lilly. R. Berent: medical director, Center for cardiovascular rehabilitation, HerzReha Bad Ischl, speakers fee and consultant of Novartis, Boehringer Ingelheim, Merck, MSD, Servier, Pfizer, Amgen, Sanofi-Aventis. R. Berger: Research grant, speakers fee and consultant of Abbott, Amgen, Bayer, Biotronic, Boehringer Ingelheim, Cardinal Health, Medtronic, Novartis, Orion Pharma, Servier. A. Boehmer: director of RPP Kardiologische Versorgung Modellregion Waldviertel, research grant, speakers fee or consultant of Novartis, Orion Pharma, Boehringer, Merck, Servier, Boston. C. Ebner: research grant, speakers fee by or consultant of Abbott, Merck, Novartis, Orion, Pfizer, Servier, Vifor. M. Fritsch: DGKS, nurse at the University Clinic of Salzburg, Cardiology Section, Heart Failure consultant, leading nurse of the “Cardiomobil” project of Salzburg. F. Geyrhofer: Kardiologischer Administrator Ordensklinikum Linz, speakers fee and consultant of Core. M. Huelsmann: research grant, speakers fee by or consultant of Abbott, Gebro, Merck, Novartis, Pfizer, Roche Diagnostics, MSD, Pint Pharma, Servier, Thermo Fisher. G. Poelzl: director of the HerzMobil Tyrol DMP. Research grant, speakers fee by or consultant of Abbott, Merck, Novartis, Orion, Pfizer, Servier, Vifor. T. Stefenelli: research grant from Sorin; board and speakers fees from Astra-Zeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Genericon, Menarini, MSD, Novartis, Orion, Servier, Takeda, Vifor. None of the authors have a financial relationship with the Austrian Society of Cardiology, the institution which sponsored this manuscript.

PY - 2017/12/1

Y1 - 2017/12/1

KW - Aged

KW - Austria

KW - Cardiology

KW - Heart Failure

KW - Humans

KW - Quality of Life

KW - Societies, Medical

UR - http://www.scopus.com/inward/record.url?scp=85032482050&partnerID=8YFLogxK

U2 - 10.1007/s00508-017-1265-0

DO - 10.1007/s00508-017-1265-0

M3 - Journal article

C2 - 29080104

SN - 0043-5325

VL - 129

SP - 869

EP - 878

JO - Wiener Klinische Wochenschrift

JF - Wiener Klinische Wochenschrift

IS - 23-24

ER -